A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene. (Q40512045)
Jump to navigation
Jump to search
scientific article published on May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene. |
scientific article published on May 2004 |
Statements
A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene (English)
Ayala Tamir
Nicholas Bates
Elizabeth Flanagan
Martin E Gore
Desmond P J Barton
Peter Harper
Michael Seckl
Hilary Thomas
Nicholas R Lemoine
Mark Charnock
Nagy A Habib
Robert Lechler
Joanna Nicholls
Massimo Pignatelli
Trivadi S Ganesan